PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Japan Hospice Holdings Inc.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Japan Hospice Holdings Inc. owes ¥0.80 for every ¥1 it owns. Net profit fell 57% in the year to Dec 2025, and shrank 15% a year on average over 3 years.

Compared with Healthcare companies in Japan · latest annual results Dec 2025.

P/E ratio

11.9

Investors pay ¥11.9 for every ¥1 of Japan Hospice Holdings Inc.'s yearly profit, lower than 72% of Healthcare companies in Japan.

P/B ratio

1.07

The share price is 1.07 times Japan Hospice Holdings Inc.'s book value per share, lower than 72% of Healthcare companies in Japan.

Market cap

¥3.9 B

The total market value of all of Japan Hospice Holdings Inc.'s shares at today's price (share price × number of shares), smaller than 83% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥3.7 B

What Japan Hospice Holdings Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥431.76

Net worth divided by the number of shares. The share price of ¥462.00 is 1.1 times this, which is the P/B above.

Return on equity (ROE)

9.2%

Japan Hospice Holdings Inc. earned 9.2% on its shareholders' money over the last year, higher than 60% of Healthcare companies in Japan.

Owes vs Owns

0.80×

Japan Hospice Holdings Inc. owes ¥0.80 for every ¥1 it owns (high), higher than 92% of Healthcare companies in Japan.

Dividend yield

5.39%

Japan Hospice Holdings Inc. pays 5.39% of its share price as dividends a year, higher than 98% of dividend-paying Healthcare companies in Japan.

Revenue growth

+17%

Revenue rose 17% in the year to Dec 2025, and grew 22% a year on average over 3 years.

Profit growth

-57%

Net profit fell 57% in the year to Dec 2025, and shrank 15% a year on average over 3 years.

Profit margin

2.0%

Japan Hospice Holdings Inc. keeps ¥2 of every ¥100 of revenue as net profit.

Cash quality

3.8×

Cash from Japan Hospice Holdings Inc.'s business was 3.8× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

1.8×

Japan Hospice Holdings Inc.'s operating profit covered its interest costs 1.8 times in the year to Dec 2025.

Cash vs debt

Net debt

Japan Hospice Holdings Inc. had ¥11.2 B more debt than cash (net debt) at Dec 2025.

Questions

What is Japan Hospice Holdings Inc.'s P/E ratio?

Investors pay ¥11.9 for every ¥1 of Japan Hospice Holdings Inc.'s yearly profit, lower than 72% of Healthcare companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Japan Hospice Holdings Inc.: ¥3.9 B ÷ ¥3.7 B (30 Jun 2026) = 1.1.

What is Japan Hospice Holdings Inc.'s return on equity?

Japan Hospice Holdings Inc. earned 9.2% on its shareholders' money over the last year, higher than 60% of Healthcare companies in Japan.

How much does Japan Hospice Holdings Inc. owe compared with what it owns?

Japan Hospice Holdings Inc. owes ¥0.80 for every ¥1 it owns (high), higher than 92% of Healthcare companies in Japan.

Does Japan Hospice Holdings Inc. pay a dividend?

Yes. Japan Hospice Holdings Inc. pays 5.39% of its share price as dividends a year, higher than 98% of dividend-paying Healthcare companies in Japan.

Is Japan Hospice Holdings Inc.'s revenue growing?

Revenue rose 17% in the year to Dec 2025, and grew 22% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.